Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Liu, Ying ^a   Zhang, Wei ^a   Wang, Xiao Jie ^b   Liu, Shi ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

^b Heilongjiang Institute of Dermatology and Sexually Transmitted Disease   (China)

Author keywords

Kanglaite injection; Pancreatic cancer; PI3K Akt mTOR signaling; Traditional Chinese medicine

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; KANGLAITE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS CARCINOMA; PANCREATIC CANCER CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CHINA; DRUGS, CHINESE HERBAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84903801172     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-228     Document Type: Article

References (18)

1. Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut 2007, 56:1134-1152.
2. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK, Tang W. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 2010, 4:297-307.
3. Pan P, Wu Y, Guo ZY, Wang R, Wang YJ, Yuan YF. Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma. J Ethnopharmacol 2012, 143:680-685.
4. Guo HY, Cai Y, Yang XM, Wang ZH, Wang JL, Zhao XM, Li J, Hu XC. Randomized phase II trial on mitomycin-C/cisplatin+/-KLT in heavily pretreated advanced breast cancer. Am J Chin Med 2008, 36:665-674.
5. Zhan YP, Huang XE, Cao J, Lu YY, Wu XY, Liu J, Xu X, Xiang J, Ye LH. Clinical safety and efficacy of Kanglaite® (CoixSeedOil) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev 2012, 13:5319-5321.
6. Wu LQ, Lu Y, Lu HJ, Zhao ZG, Yang M. Efficacy of intra-tumor injection of Kang-Lai-Te in treating transplanted hepatoma in rats. Hepatobiliary Pancreat Dis Int 2004, 3:580-584.
7. Lu Y, Li CS, Dong Q. Chinese herb related molecules of cancer-cell- apoptosis: a minireview of progress between Kanglaite injection and related genes. J Exp Clin Cancer Res 2008, 27:31.
8. Lu Y, Wu LQ, Dong Q, Li CS. Experimental study on the effect of Kang-Lai-Te induced apoptosis of human hepatoma carcinoma cell HepG2. Hepatobiliary Pancreat Dis Int 2009, 8:267-272.
9. Yang AK, He SM, Liu L, Liu JP, Wei MQ, Zhou SF. Herbal interactions with anticancer drugs: mechanistic and clinical considerations. Curr Med Chem 2010, 17:1635-1678.
10. Morgan TM, Koreckij TD, Corey E. Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets 2009, 9:237-249.
11. Downward J. PI3-kinase, Akt and cell survival. Semin Cell Dev Biol 2004, 15:177-182.
12. Xu G, Zhang W, Bertram P, Zheng XF, McLeod H. Pharmacogenomic profiling of the PI3K/TEN-Akt-mTOR pathway in common human tumors. Int J Oncol 2004, 24:893-900.
13. Park JH, Darvin P, Lim EJ, Joung YH, Hong DY, Park EU, Park SH, Choi SK, Moon ES, Cho BW, Park KD, Lee HK, Kim MJ, Park DS, Chung IM, Yang YM. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts. PLoS One 2012, 7:e40531.
14. Wang CG, Yang JQ, Liu BZ, Jin DT, Wang C, Zhong L, Zhu D, Wu Y. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Eur J Pharmacol 2010, 627:33-41.
15. Saxena BB, Zhu L, Hao M, Kisilis E, Katdare M, Oktem O, Bomshteyn A, Rathnam P. Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent. Bioorg Med Chem 2006, 14:6349-6358.
16. Huang HC, Way TD, Lin CL, Lin JK. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein. Endocrinology 2008, 149:5972-5983.
17. Ye HH, Ye Z, Zhao HJ, Xu R, Wu WX, OuYang QF. Curative effect observation of ultrasound-guided intra-tumor injection of " Kang-Lai-Te" in treating transplanted hepatoma of rats. Fujian Med J (Chinese) 2008, 30:3-6.
18. Karar J, Maity A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front Mol Neurosci 2011, 4:51.